Literature DB >> 14624711

Topotecan in relapsed small-cell lung cancer: can good things come in small packages?

John R Eckardt1.   

Abstract

Entities:  

Year:  2003        PMID： 14624711     DOI： 10.1016/s1525-7304(11)70284-4

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  2 in total

1.  A Phase II Study of Weekly Paclitaxel Plus Gemcitabine as a Second-Line Therapy in Patients with Metastatic or Recurrent Small Cell Lung Cancer.

Authors:  Tak Yun; Heung Tae Kim; Ji-Youn Han; Sung Jin Yoon; Hyae Young Kim; Byung-Ho Nam; Jin Soo Lee
Journal:  Cancer Res Treat       Date:  2015-05-26       Impact factor: 4.679

Review 2.  Treatment options for small cell lung cancer - do we have more choice?

Authors:  M Puglisi; S Dolly; A Faria; J S Myerson; S Popat; M E R O'Brien
Journal:  Br J Cancer       Date:  2010-01-26       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.